Global Oncology Based In-vivo Cro Market Size & Outlook
Global oncology based in-vivo cro market, 2018-2030 (US$M)
Related Markets
Global oncology based in-vivo cro market highlights
- The global oncology based in-vivo cro market generated a revenue of USD 1,333.0 million in 2023 and is expected to reach USD 2,369.1 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 8.6% by 2030.
- In terms of segment, solid tumor accounted for a revenue of USD 629.2 million in 2023.
- Solid Tumor is the most lucrative indication segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Norway is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 1,333.0 million |
| Market revenue in 2030 | USD 2,369.1 million |
| Growth rate | 8.6% (CAGR from 2023 to 2030) |
| Largest segment | Solid tumor |
| Fastest growing segment | Solid Tumor |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Blood Cancer, Solid Tumor |
Other key industry trends
- In terms of revenue, the North America accounted for 50.0% of the global oncology based in-vivo cro market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Norway is the fastest growing regional market and is projected to reach USD 6.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oncology Based In-vivo CRO Market Scope
Oncology Based In-vivo CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global oncology based in-vivo cro market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology based in-vivo cro market will help companies and investors design strategic landscapes.
Solid tumor was the largest segment with a revenue share of 47.2% in 2023. Horizon Databook has segmented the Global oncology based in-vivo cro market based on blood cancer, solid tumor covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Oncology Based In-vivo CRO Indication Outlook (Revenue, USD Million, 2018-2030)
- Blood Cancer
- Solid Tumor
- Syngeneic Model
- Patient Derived Xenograft
- Xenograft
- Others
Reasons to subscribe to Global oncology based in-vivo cro market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global oncology based in-vivo cro market databook
-
Our clientele includes a mix of oncology based in-vivo cro market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global oncology based in-vivo cro market , including forecasts for subscribers. This global databook contains high-level insights into Global oncology based in-vivo cro market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global oncology based in-vivo cro market size, by regions, 2018-2030 (US$M)
Top 10 countries: Oncology based in-vivo cro market size, 2023 (US$M)
Global oncology based in-vivo cro market share, by indication, 2023 & 2030 (%, US$M)
Oncology based in-vivo cro market: Opportunity assessment by country
Global oncology based in-vivo cro market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
